Bharat Parenterals Management Change

Bharat Parenterals Earnings Call Transcript: Key Takeaways

Q2 FY27 consolidated revenue ₹136.3 Cr (+110% YoY, +45% QoQ) and PAT ₹11.8 Cr, the first group profit quarter, led by Innoxel. Standalone margins squeezed by input costs; FY27 guidance maintained.

Bharat Parenterals Investor Presentation: Key Takeaways

Q2 FY27 consolidated revenue ₹136.3 Cr (+110.9% YoY), EBITDA ₹23.6 Cr (17.3%), PAT ₹11.8 Cr; Innoxel turned profitable.

Bharat Parenterals Q2 FY27 Results: Turns Profitable, Net Profit ₹11.8 Cr

Bharat Parenterals approved unaudited standalone results for the quarter ended 30 September 2026. The company reported profit and revenue growth versus the prior-year quarter.

Key figure

Net profit ₹11.8 Cr

Bharat Parenterals Board Meeting Date

Bharat Parenterals will hold a board meeting on October 29, 2026 to consider unaudited standalone and consolidated results. Trading window has been closed since October 1, 2026.

Bharat Parenterals Annual General Meeting

Bharat Parenterals held an EGM via video conferencing on October 23, 2026. Members considered a preferential equity issue and Section 186 investment and guarantee limits.

Bharat Parenterals Business Update

Innoxel Lifesciences, a Bharat Parenterals subsidiary, began U.S. commercial supply of its first CMO product. This adds recurring manufacturing revenue to its existing licensing income.

Wonder Electricals Management Change

Wonder Electricals disclosed the resignation of Independent Director Bhawna Saunkhiya, citing other professional commitments. The filing supplements an exchange query on the November 5 announcement.

Baba Arts Management Change

Baba Arts Limited's Company Secretary and Compliance Officer, Naishadh Mankad, resigned effective 6 November 2026. Shilpi Shukla was appointed to the same role from that date.

Manappuram Finance Management Change

Manappuram Finance's Group Chief Technology Officer, Narayanan Easwaran, resigned effective close of business November 7, 2026, citing personal reasons. The resignation letter is attached as required under Regulation 30.

Aarnav Fashions Management Change

Aarnav Fashions appointed Lalchand Manfoolram Saharan as Executive Director for a 60-month term, effective 3 November 2026. The appointment was approved at a board meeting held the same day.

Execution

60 months

GRE Renew Enertech Management Change

GRE Renew Enertech appointed Alpeshkumar Laxmanji Agrawal as Chief Financial Officer with immediate effect from 6 November 2026. The board approved the appointment on remuneration terms.

RNFI Services Management Change

RNFI Services appointed Sameer Nagpal as Group Chief Operating Officer effective 6 November 2026. He is also designated Senior Management Personnel.